1 year on.
$15m pa for only Europe from this generic manufacturer.
Drug to be granted approval this fiscal year. Only 2 weeks left.
Was the drug approved? Sec requires UNS to notify us either way.
Where's the initial payments? Did it show as revenue?
Is this deal even included in the $1b pipeline?
I think this needs some deep analysis.
